“Blood Testing Market Report is set to have rapid growth due to constantly increasing geriatric population, advanced technological facilities and introduction of advanced technologies for the POC blood tests at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Blood Testing Market Report: By Test Type (Glucose, Lipid, BUN, A1C, CRP, Vitamin D, ALT, AST, Thyroid Stimulating Hormone), By Region, And Segment Forecasts
With increasing need for identification of infectious agents, cardiovascular diseases, cancer biomarkers, drug abuse, and women’s health issues blood testing market is expected to witness huge growth. A blood test can be used for various ailments like anaemia, infection, leukaemia, hypokalaemia, and kidney abnormalities besides cancer detection. Blood tests have also played great role in lab diagnosis, essential for treatment initiation.
Advancement in technologies have allowed blood testing to be precise, accurate requiring only a drop of blood to assess a biomarker instead of opting for a invasive process. Blood testing also allows for early diagnosis of a disease producing better health outcomes for a patient. Development in blood collecting procedures, analysers, sensors, automated blood testing with seamless transfer of information via digital therapeutics will see the blood testing market boom.
Leading companies featured in the report include Abbott Diagnostics, Bio-Rad Laboratories Inc, Roche Diagnostics, Quest Diagnostics, Biomerica, Inc, Siemens Healthineers (A Subsidiary of Siemens AG), Trinity Biotech PLC, Alere Inc, Beckman Coulter (A Subsidiary Of Danaher Corporation), Becton, Dickinson And Company.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global Bioreactors market was estimated to be valued at US$ 9,9770.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.
29 September 2023
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
27 September 2023
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
25 September 2023
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.